A Third-Order Differential Equation and Starlikeness of a Double Integral Operator

Functions f(z)= z+E°2 anzn that are analytic in the unit disk and satisfy the differential equation f'(z) + azf"(z)+yz2f"(z) = g(z) are considered, where g is subordinated to a normalized convex univalent function h. These functions f are given by a double integral operator of the form f(z) = (10(10G(ztμsν�t−μs−νds dt with G" subordinated to h. The best dominant to all solutions of the differential equation is obtained. Starlikeness properties and various sharp estimates of these solutions are investigated for particular cases of the convex function h

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach

BACKGROUND: The World Health Organization (WHO) currently recommends height or age-based dosing as alternatives to weight-based dosing for mass drug administration lymphatic filariasis (LF) elimination programs. The goals of our study were to compare these alternative dosing strategies to weight-based dosing and to develop and evaluate new height-based dosing pole scenarios. METHODOLOGY/PRINCIPAL FINDINGS: Age, height and weight data were collected from \u3e26,000 individuals in five countries during a cluster randomized LF clinical trial. Weight-based dosing for diethylcarbamazine (DEC; 6 mg/kg) and ivermectin (IVM; 200 ug/kg) with tablet numbers derived from a table of weight intervals was treated as the gold standard for this study. Following WHO recommended age-based dosing of DEC and height-based dosing of IVM would have resulted in 32% and 27% of individuals receiving treatment doses below those recommended by weight-based dosing for DEC and IVM, respectively. Underdosing would have been especially common in adult males, who tend to have the highest LF prevalence in many endemic areas. We used a 3-step modeling approach to develop and evaluate new dosing pole cutoffs. First, we analyzed the clinical trial data using quantile regression to predict weight from height. We then used weight predictions to develop new dosing pole cutoff values. Finally, we compared different dosing pole cutoffs and age and height-based WHO dosing recommendations to weight-based dosing. We considered hundreds of scenarios including country- and sex-specific dosing poles. A simple dosing pole with a 6-tablet maximum for both DEC and IVM reduced the underdosing rate by 30% and 21%, respectively, and was nearly as effective as more complex pole combinations for reducing underdosing. CONCLUSIONS/SIGNIFICANCE: Using a novel modeling approach, we developed a simple dosing pole that would markedly reduce underdosing for DEC and IVM in MDA programs compared to current WHO recommended height or age-based dosing

A multi-center, open-labeled, cluster-randomized study of the safety of double and triple drug community mass drug administration for lymphatic filariasis

BackgroundThe Global Programme to Eliminate Lymphatic Filariasis (GPELF) provides antifilarial medications to hundreds of millions of people annually to treat filarial infections and prevent elephantiasis. Recent trials have shown that a single-dose, triple-drug treatment (ivermectin with diethylcarbamazine and albendazole [IDA]) is superior to a two-drug combination (diethylcarbamazine plus albendazole [DA]) that is widely used in LF elimination programs. This study was performed to assess the safety of IDA and DA in a variety of endemic settings.Methods and findingsLarge community studies were conducted in five countries between October 2016 and November 2017. Two studies were performed in areas with no prior mass drug administration (MDA) for filariasis (Papua New Guinea and Indonesia), and three studies were performed in areas with persistent LF despite extensive prior MDA (India, Haiti, and Fiji). Participants were treated with a single oral dose of IDA (ivermectin, 200 μg/kg; diethylcarbamazine, 6 mg/kg; plus albendazole, a fixed dose of 400 mg) or with DA alone. Treatment assignment in each study site was randomized by locality of residence. Treatment was offered to residents who were ≥5 years of age and not pregnant. Adverse events (AEs) were assessed by medical teams with active follow-up for 2 days and passive follow-up for an additional 5 days. A total of 26,836 persons were enrolled (13,535 females and 13,300 males). A total of 12,280 participants were treated with DA, and 14,556 were treated with IDA. On day 1 or 2 after treatment, 97.4% of participants were assessed for AEs. The frequency of all AEs was similar after IDA and DA treatment (12% versus 12.1%, adjusted odds ratio for IDA versus DA 1.15, 95% CI 0.87-1.52, P = 0.316); 10.9% of participants experienced mild (grade 1) AEs, 1% experienced moderate (grade 2) AEs, and 0.1% experienced severe (grade 3) AEs. Rates of serious AEs after DA and IDA treatment were 0.04% (95% CI 0.01%-0.1%) and 0.01% (95% CI 0.00%-0.04%), respectively. Severity of AEs was not significantly different after IDA or DA. Five of six serious AEs reported occurred after DA treatment. The most common AEs reported were headache, dizziness, abdominal pain, fever, nausea, and fatigue. AE frequencies varied by country and were higher in adults and in females. AEs were more common in study participants with microfilaremia (33.4% versus 11.1%, P ConclusionsIn this study, we observed that IDA was well tolerated in LF-endemic populations. Posttreatment AE rates and severity did not differ significantly after IDA or DA treatment. Thus, results of this study suggest that IDA should be as safe as DA for use as a MDA regimen for LF elimination in areas that currently receive DA.Trial registrationClinicaltrials.gov registration number: NCT02899936

Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration

Neural tissue repair and regeneration strategies have received a great deal of attention because it directly affects the quality of the patient's life. There are many scientific challenges to regenerate nerve while using conventional autologous nerve grafts and from the newly developed therapeutic strategies for the reconstruction of damaged nerves. Recent advancements in nerve regeneration have involved the application of tissue engineering principles and this has evolved a new perspective to neural therapy. The success of neural tissue engineering is mainly based on the regulation of cell behavior and tissue progression through the development of a synthetic scaffold that is analogous to the natural extracellular matrix and can support three-dimensional cell cultures. As the natural extracellular matrix provides an ideal environment for topographical, electrical and chemical cues to the adhesion and proliferation of neural cells, there exists a need to develop a synthetic scaffold that would be biocompatible, immunologically inert, conducting, biodegradable, and infection-resistant biomaterial to support neurite outgrowth. This review outlines the rationale for effective neural tissue engineering through the use of suitable biomaterials and scaffolding techniques for fabrication of a construct that would allow the neurons to adhere, proliferate and eventually form nerves

What is Information Worth for an Extra Quintal of Grain?: Randomised Experimental Evidence from Farmers in India

This study evaluates whether access to real-time customised idiosyncratic agricultural information over extended seasons improves the value of such information among farmers. We conduct a controlled randomised experiment in the Indian state of Karnataka. The study employs the difference-in-difference method to a panel of households comparing the differential valuation of information during the post-intervention period between treatment (participant) and control (non-participant) farmers relative to the outcomes observed during a pre-intervention period. We find robust evidence of the intervention showing significantly positive impacts on the valuation of agricultural information among treatment farmers relative to the control farmers. A difference of each one unit improvement in information access is found to be associated with 53 percent average increase in the mean valuation of the information. The result indicates that farmers value information that is comprehensive, reliable, real-time and idiosyncratic as opposed to the more generic or piecemeal information

Timing Aware Partitioning for Multi-FPGA based Logic Simulation using Top-down Selective Flattening

In order to accelerate logic simulation, it is highly beneficial to simulate the circuit design on FPGA hardware. However, limited hardware resources on FPGAs prevent large designs from being implemented on a single FPGA. Hence there is a need to partition the design and simulate it on a multi-FPGA platform. In contrast to existing FPGA-based post-synthesis partitioning approaches which first completely flatten the circuit and then possibly perform bottom-up clustering, we perform a selective top-down flattening and thereby avoid the potential netlist blowup. This also allows us to preserve the design hierarchy to guide the partitioning and to make subsequent debugging easier. Our approach analyzes the hierarchical design and selectively flattens instances using two metrics based on slack. The resulting partially flattened netlist is converted to a hypergraph, partitioned using a public domain partitioner (hMetis), and reconverted back to a plurality of FPGA netlists, one for each FPGA of the FPGA-based accelerated logic simulation platform. We compare our approach with a partitioning approach that operates on a completely flattened netlist. Static timing analysis was performed for both approaches, and over 15 examples from the OpenCores project, our approach yields a 52% logic simulation speedup and about 0.74x runtime for the entire flow, compared to the completely flat approach. The entire tool chain of our approach is automated in an end-to-end flow from hierarchy extraction, selective flattening, partitioning, and netlist reconstruction. Compared to an existing method which also performs slack-based partitioning of a hierarchical netlist, we obtain a 35% simulation speedup